Back to the search results

AGAPLESION Evangelisches Krankenhaus Mittelhessen gGmbH (Gießen)

Paul-Zipp-Straße 171
35398 Gießen

Phone: 0641-9606-0
Mail: ed.noiselpaga@MKE.fg.kes ed.noiselpaga@MKE.fg.kes ed.noiselpaga@MKE.fg.kes

http://www.ekm-gi.de/

Basic information

Number of beds: 263
Number of specialist departments: 15

Number of inpatient cases: 11.556
Number of partial inpatient cases: 1
Number of outpatient cases: 27.280

Hospital owners: AGAPLESION EVANGELISCHES KRANKENHAUS MITTELHESSEN gGmbH
Type of provider: freigemeinnützig

Academic teaching hospital

Specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	yes
Bezeichnung
Teilnahme externe Qualitätssicherung	yes
Bezeichnung
Teilnahme externe Qualitätssicherung	no

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Implementation of the minimum quantity agreement

Treatment area

Knee joint total endoprostheses

Quantity performed	128
Exception?	No exception

Minimum quantities forecast

Knee joint total endoprostheses

Overall result forecast presentation:	yes
Quantity performed reporting year:	128
Quantity forecast year:	102
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ28	Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction)
CQ30	Quality assurance guideline for interstitial LDR brachytherapy for low-risk localized prostate cancer (effective January 8, 2021).

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Management of quality assurance for proximal femoral fracturet (QSFFx)

Full record of compliance maintained

Number of days shown	366
Days of non-performance	67
Number of minimum requirements not met	5

General minimum requirements

Minimum requirement	Days of non-performance
Trauma room	0
Availability	0
Computed tomography (CT)	0
Intensive care beds	0
Department of Surgery	0
Forwarding by air	0
Department of Internal Medicine	0
Intensive care beds with ventilator facilities	0
Emergency care training courses	0
Treatment prioritisation system (triage)	0
Responsibility for emergency care	0

Specific minimum requirements

Minimum requirement	Days of non-performance
Doctor on duty	0
Supervision by a medical specialist	0
Geriatric expertise	0
Operating room equipment	0
Post-operative physiotherapy	0
Independent organisational unit	0

Minimum requirements for process quality

Minimum requirement	Days of non-performance
SOP: Surgical procedures	67
SOP: Perioperative Planning	67
SOP: Capacity to consent	0
Standard Operating Procedure for the Management of Anticoagulants	67
SOP: Ortho-geriatric Care	67
SOP: Physiotherapy Measures	67
SOP: Patient-centred blood management	0

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
56	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
50	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
46	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
No care for children and young people

Commentary on the protection concept

Gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß Teil A § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Use of standardised forms for drug medical history

EKM Medikamentenmanagement

06.05.2025

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

roXtra

18.01.2022

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Uni Marburg (APL-Professur) Med. Hochschule Hannover (Humanmed.) JLU Gießen (Ethik, Humanmed., Handchirurgie, Innere Med., Molecular Biology and Medicine of the Lung, Advanced Clinician Scientist Programms "JLU-LIFT" (BMBF), Clinician Scientists Programms "JLU CAREER" (DFG)) Goethe Uni Ffm (QB7)

FL02 - Lectureships / teaching posts at universities of applied sciences

Explanation

Lehrbeauftragung - Fresenius FH in Köln, Idstein und Düsseldorf für den Studiengang Physiotherapie. Carl-Oelemann-Schule der Landesärztekammer Hessen. Vorlesungen - Neurologie für Fachpflege Anästhesie/Intensivmedizin, Frankfurt. Faculty Member DZL Academy - Deutsches Zentrum für Lungenforschung

FL03 - Student training (clinical traineeship / internship year)

Explanation

Als akad. Lehr-KH werden Med.-Studenten im prakt. Jahr in der Innere Medizin, Chirurgie, Plastische Chirurgie, Anästhesie, Strahlenschutz/ Radiologie und Intensivmedizin ausgebildet. Bed side teaching und strukturierte Ausbildung für Med.-Studenten; Med. Staatsexamen im EKM; Vorlesungen am UKGM

FL04 - Project-related cooperation with colleges and universities

Explanation

Projekte mit der JLU Gießen, KI TU München, Sektion Medinformatik, UKGM. Enge Verzahnung mit JLU GI im Rahmen pneumol. Forschungsschwerpunkte. Teilnahme am europ. ILD Register und Biobank; Biobank des Deut. Zentr. für Lungenforschung; an wissenschaftl. Analysen bei Patienten mit Bronchialkarzinom

FL08 - Editors of scientific journals/textbooks

Explanation

Regelmäßige Publikationen in internationalen Journals (Plast. Chirurgie). Mitautor Anästhesielehrbuchreihe.

FL09 - Doctoral supervision

Explanation

an der JLU Gießen für Plast. Chirurgie, Pneumologie, Anästhesie

FL06 - Participation in multi-centre phase III/IV studies

Explanation

2 PhIII in Planung (Pneumologie) Knie- und Hüft-TEP Studien Fa. Implantcast (Orthopädie)

FL05 - Participation in multi-centre Phase I/II studies

Explanation

Interventionelle LTI-03, INSURF, Metformin IPF, WHISTLE Studien bei Lungenfibrose. Zwei Ph II in Planung

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

Koordination des europäischen ILD-Registers und der Biobank; Koordination INSURF (inhalatives Surfactant bei IPF) und Metformin-IPF (systemische Metformintherapie bei IPF); Beteiligung an multizentrischen Studien (Stopp Malnutrition, Delirstudie, MUSE); präklinische Forschung mit LK Gießen

Training

Training in other healing professions

HB01 - Nurse and health care worker (m/f)

Comment

An das Krankenhaus angeschlossen und in Kooperation mit anderen Krankenhäusern, betreiben wir das Christliche Bildungszentrum für Gesundheitsberufe Mittelhessen (CBG). Hierzu wurde ein gem. Trägerverein gegründet. In der Einrichtung findet die Ausbildung zum Gesundheits- und Krankenpfleger statt.

HB07 - Surgical technical assistant (m/f)

Comment

Betreffend der Ausbildung von Operationstechnischen Assistenten (OTA), besteht eine Kooperation zwischen unserem Haus und der DRK-Schwesternschaft Marburg e.V.

HB17 - Auxiliary nurse (m/f)

Comment

Mit der Krankenpflegehilfeschule der DRK-Schwesternschaft Marburg e.V. besteht eine Kooperation zur Ausbildung von Krankenpflegehelfern in unserem Haus.

HB15 - Anaesthesia technical assistant (m/f)

Comment

Betreffend der Ausbildung von Anästhesietechnischen Assistenten (ATA), besteht eine Kooperation zwischen unserem Haus und der DRK-Schwesternschaft Marburg e.V.

HB06 - Occupational therapist (m/f)

Comment

Ausbildung Ergotherapeut:innen, seit September 2024 besteht eine Kooperation mit der Hephata Ergotherapieschule Fokus gGmbH, über die Praktika bei uns absolviert werden.

Hospital staff
Pharmaceutical personnel
- Number of pharmacists: 8
- Additional staff: 5
- Explanations: Die Arzneimittelversorgung erfolgt über einen Versorgungsvertrag durch die Krankenhausapotheke der FRANKFURTER DIAKONIE KLINIKEN GmbH. Regelmäßige Sitzungen, Begehungen sowie Schulungen (z. B. Zytostatika) finden statt. Informationen zur Arzneimitteltherapiesicherheit werden zur Verfügung gestellt.
- Nursing staff regulation